-+ 0.00%
-+ 0.00%
-+ 0.00%

Valneva, Pfizer Lyme vaccine application clears EMA validation step

PUBT·08/14/2026 05:00:41
Listen to the news
Valneva, Pfizer Lyme vaccine application clears EMA validation step
  • EMA validated the marketing authorization application for Pfizer-Valneva’s Lyme disease vaccine candidate PF-07307405, starting its EU review.
  • Filing based on Phase 3 VALOR data showing more than 70% efficacy; trial reported no safety concerns.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Valneva SE published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608140100PRIMZONEFULLFEED1001257543) on August 14, 2026, and is solely responsible for the information contained therein.